ArticleCancers2025

Dynamic Changes in Albumin and Systemic Immune-Inflammation Index as Prognostic Markers in Patients Treated with Cabozantinib After Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma.

Rikushi Fujimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.